Loading...
Please wait, while we are loading the content...
Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD
| Content Provider | Scilit |
|---|---|
| Author | Edmonston, Daniel Wojdyla, Daniel Mehta, Rupal Cai, Xuan Lora, Claudia Cohen, Debbie Townsend, Raymond R. He, Jiang Go, Alan S. Kusek, John Weir, Matthew R. Isakova, Tamara Pencina, Michael Wolf, Myles Appel, Lawrence J. Feldman, Harold I. Lash, James P. Rao, Panduranga S. Rahman, Mahboob |
| Copyright Year | 2019 |
| Description | Journal: American Journal of Kidney Diseases |
| Related Links | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875624/pdf http://www.ajkd.org/article/S0272638619308480/pdf |
| Ending Page | 781 |
| Page Count | 11 |
| Starting Page | 771 |
| ISSN | 02726386 |
| e-ISSN | 15236838 |
| DOI | 10.1053/j.ajkd.2019.05.026 |
| Journal | American Journal of Kidney Diseases |
| Issue Number | 6 |
| Volume Number | 74 |
| Language | English |
| Publisher | Elsevier BV |
| Publisher Date | 2019-12-01 |
| Access Restriction | Open |
| Subject Keyword | Journal: American Journal of Kidney Diseases Endocrinology and Metabolism Fibroblast Growth Factor 23 (fgf23) Chronic Kidney Disease (ckd) End-stage Renal Disease (esrd) Clinical Risk Prediction Heart Failure (hf) Atherosclerotic Disease Cardiovascular Mortality |
| Content Type | Text |
| Resource Type | Article |
| Subject | Nephrology |